Drug Pricing Policies
The price of medicines is one of the factors that can limit the affordability of medicines to the population. So there are many drug pricing policies that could be implemented by the regulatory authorities based on the level of control they intend to implement on drug prices in the national market to assure that drugs are available in the market at fair prices. The national regulatory authority may follow one policy or combination of more than one of pricing policies to assure the fair pricing of medicines registered in their market.So the company should be aware of those policies and what policy the intended market regulatory authority is applying, so it can predict the range of prices that its product may acquire.In this webinar, we will discuss the different policies applied by the regulatory authorities and the power of negotiation that the company may have against the authority. Also, we will discuss the different terminologies in drug pricing to be aware of each item in the pricing structure.Areas Covered Helicopter view on international pricing of drugsFactors considered by the payers and regulatory authorities when deciding on drug pricesDifferent types of pricing systemsNational pricing policies and systems in different countries for innovative & generic productsDifferent pricing techniques and the differences between themDrug pricing terms (Ex-factory, FOB, CIF, retail…etc)Who Should Attend Top management in pharmaceutical companiesRegulatory affairs professionals Business improvement delegatesMarket access delegatesExport professionalsAnyone involved in the drug pricing processWhy Should You Attend Understand the different terminologies used in drug pricingUnderstand the different policies in drug pricingBe aware of the current rules of drug pricing in different countriesBe aware of factors affecting the dug pricingTopic Background Access to medicines is a human right, and some countries incorporate it in their national constitution. The price of medicines is one of the factors that can limit the affordability of medicines to the population. There are many drug pricing policies that could be implemented by the regulatory authorities based on the level of control they intend to implement on drug prices in the national market.The national regulatory authority may follow one policy or combination of more than one of pricing policies to assure the fair pricing of medicines registered in their market.By the end, drug pricing, as it is called by many experts, “The moment of truth” as it is the moment where you, as a pharmaceutical company, know if you can have the return on investment you invested in developing the new medicines or not.
Single
The price of medicines is one of the factors that can limit the affordability of medicines to the population.
So there are many drug pricing policies that could be implemented by the regulatory authorities based on the level of control they intend to implement on drug prices in the national market to assure that drugs are available in the market at fair prices.
The national regulatory authority may follow one policy or combination of more than one of pricing policies to assure the fair pricing of medicines registered in their market.
So the company should be aware of those policies and what policy the intended market regulatory authority is applying, so it can predict the range of prices that its product may acquire.
In this webinar, we will discuss the different policies applied by the regulatory authorities and the power of negotiation that the company may have against the authority. Also, we will discuss the different terminologies in drug pricing to be aware of each item in the pricing structure.
Areas Covered
- Helicopter view on international pricing of drugs
- Factors considered by the payers and regulatory authorities when deciding on drug prices
- Different types of pricing systems
- National pricing policies and systems in different countries for innovative & generic products
- Different pricing techniques and the differences between them
- Drug pricing terms (Ex-factory, FOB, CIF, retail…etc)
Who Should Attend
- Top management in pharmaceutical companies
- Regulatory affairs professionals
- Business improvement delegates
- Market access delegates
- Export professionals
- Anyone involved in the drug pricing process
Why Should You Attend
- Understand the different terminologies used in drug pricing
- Understand the different policies in drug pricing
- Be aware of the current rules of drug pricing in different countries
- Be aware of factors affecting the dug pricing
Topic Background
Access to medicines is a human right, and some countries incorporate it in their national constitution.
The price of medicines is one of the factors that can limit the affordability of medicines to the population.
There are many drug pricing policies that could be implemented by the regulatory authorities based on the level of control they intend to implement on drug prices in the national market.
The national regulatory authority may follow one policy or combination of more than one of pricing policies to assure the fair pricing of medicines registered in their market.
By the end, drug pricing, as it is called by many experts, “The moment of truth” as it is the moment where you, as a pharmaceutical company, know if you can have the return on investment you invested in developing the new medicines or not.